glp-1 colorectal cancer death risk study november 2025 ASCO GI 2026: receptor agonists (GLP-1s) may help reduce the of developing Glucagon-like peptide 1 receptor agonists

Competing interests LR has received a grant from Novo Nordisk Foundation (grant number: NNF24OC0091713) for an investigator sponsored randomized controlled trial for which Mylife Diabetes Care AG donates insulin pumps and accessories and Abbott donates continued glucose monitoring devices, and participated in the European Association for the Study of Diabetes annual meeting 2023 as an invite by Novo Nordisk

This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator

Color changes indicate problems

Long-term prospective studies and well-designed interventions are essential to evaluate effects on thyroid function, immune response, and patient-centered outcomes

Sometimes weight loss injections are covered

Help Center Terms of Service Privacy Policy Cookie Policy Imprint Ads info 2026 X Corp